Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» type 2 diabetes
type 2 diabetes
Regulus reports a trio of pipeline setbacks
BioPharma Dive
Tue, 06/13/17 - 12:00 pm
Regulus
RG-101
RGLS5040
RG-105
cholestatic disease
type 2 diabetes
hepatitis C
Johnson & Johnson's Analyst Day Was Overshadowed by This Worrisome Data
Motley Fool
Tue, 05/30/17 - 10:05 am
JNJ
Invokana
type 2 diabetes
FDA Adds Boxed Warning to Janssen's Type 2 Diabetes Drug Label
RAPS.org
Tue, 05/16/17 - 10:48 pm
FDA
Janssen
type 2 diabetes
warnings
Invokana
Invokamet
Novo Nordisk launches Xultophy diabetes therapy in U.S.
Mass Device
Thu, 05/4/17 - 09:45 am
Novo Nordisk
Xultophy
diabetes
type 2 diabetes
insulin degludec
liraglutide
MannKind Hopes To Reverse Fortunes With Television Show
Seeking Alpha
Wed, 05/3/17 - 02:17 pm
MannKind
television ads
diabetes
type 2 diabetes
DTC advertising
Virta Health looks to reverse, not treat, Type II diabetes
Drug Delivery Business News
Wed, 03/8/17 - 05:36 pm
Virta Health
type 2 diabetes
diabetes
devices
patients
mobile apps
Merck, Pfizer line up a big FDA decision on a blockbuster hopeful, staring down some major league competition
Endpoints
Tue, 03/7/17 - 11:55 am
Merck
Pfizer
FDA
ertugliflozin
diabetes
type 2 diabetes
J&J touts NEJM publication of 5-year Type II diabetes bariatric surgery study
Mass Device
Fri, 02/17/17 - 09:57 am
JNJ
Ethicon
devices
type 2 diabetes
bariatric surgery
FDA Clears New Tool for Patients with Type 2 Diabetes
Qmed
Thu, 12/15/16 - 10:18 am
diabetes
FDA
JNJ
type 2 diabetes
LifeScan
blood glucose monitoring
WellDoc
Lilly Shares Spike On Jardiance Approval (LLY)
Investopedia
Sat, 12/3/16 - 12:04 am
Eli Lilly
FDA
Jardiance
type 2 diabetes
cardiovascular death
Johnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug
Market Realist
Mon, 09/26/16 - 09:58 am
JNJ
FDA
type 2 diabetes
diabetes
Invokamet XR
Janssen
U.S. FDA expands indication for type 2 diabetes treatment Synjardy to include treatment-naïve adults
Yahoo
Wed, 07/20/16 - 02:25 pm
diabetes
Synjardy
type 2 diabetes
New Jardiance® (empagliflozin) data show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes
Yahoo
Sun, 06/12/16 - 09:56 pm
type 2 diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
AstraZeneca Presents New Data from Multiple Studies on the Effect of BYDUREON on Glucose Fluctuations in Patients with Type 2 Diabetes
Yahoo
Sun, 06/12/16 - 12:29 pm
AstraZeneca
Bydureon
clinical trials
diabetes
type 2 diabetes
Diabetes 'Unicorn' Intarcia Hits Major Milestone
Fortune
Fri, 05/6/16 - 10:33 am
Intarcia
diabetes
type 2 diabetes
IPOs
ITCA 650
Zafgen Soars on Positive Phase 2 Results
24/7 Wall St
Thu, 02/18/16 - 09:42 am
Zafgen
clinical trials
beloranib
obesity
type 2 diabetes
Sanofi Reports Positive Top-Line Results in Second Pivotal LixiLan Phase III Study
Yahoo
Mon, 09/14/15 - 08:46 am
Sanofi
LixiLan-L
type 2 diabetes
Bad News Type 2 Diabetics: The FDA Is Out With Another Warning
Motley Fool
Mon, 09/7/15 - 11:38 am
FDA
type 2 diabetes
DPP-4 inhibitor
SGLT2 inhibitor
Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial
Bizjournals.com
Tue, 08/18/15 - 09:26 pm
Intarcia
Merck
diabetes
type 2 diabetes
devices
ITCA 650
Januvia
Sanofi's diabetes combo clears a clinical hurdle in a race with Novo Nordisk
Fierce Biotech
Wed, 07/29/15 - 09:51 pm
Sanofi
diabetes
type 2 diabetes
LixiLan
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »